Machinery / Industrial Parts & Tools

Recently, Intracom, the global leader in electric staplers, announced that it has completed a series D financing of 100 million yuan. Introcom is the first manufacturer in the world to launch a full range of electric smart stapler products. At present, Intracom's overall platform-based electric solution has been officially launched, marking the domestic stapler entering the era of comprehensive intelligent electronic control.

The bonus of open stapler has receded, and the tuyere of endoscopic stapler has come

As a surgical instrument, the stapler is widely used in surgical operations. According to different surgical methods, staplers are divided into open staplers and endoscopic staplers. According to different power modes, endoscopic staplers can be divided into manual endoscopic staplers and electric endoscopic staplers.

As China's aging degree further deepens, the incidence of various types of diseases will further rise. Due to the improvement of residents' living standards, medical reform will reduce the proportion of patient treatment costs, and the demand for surgery will continue to grow. The stapler market is expanding rapidly, and the sales growth rate of endoscopic staplers has exceeded 30%.

As the stapler enters the centralized procurement, the price of the stapler is falling rapidly. At present, staplers have been purchased in many provinces. Among them, in the centralized procurement of Jiangsu Province, a major stapler production province, the linear stapler of more than two thousand yuan has been reduced to more than one hundred yuan, and the hemorrhoid stapler of four to five thousand yuan It fell to two to three hundred yuan, an average drop of 83.93%, and the highest drop of 96.29%.

At present, the types of staplers collected in the collection are mainly open staplers. In the field of open staplers, due to relatively low technical requirements and patent barriers, domestic brands have gradually emerged in recent years and now occupy half of the domestic market share, and the market has entered the Red Sea competition.

Due to the high technical requirements of endoscopic staplers, there are few domestic manufacturers and their share is low. With the rapid development of minimally invasive surgery technology, the endoscopic stapler market will continue to accelerate its expansion. Among them, the electric laparoscopic stapler is simple to operate, saves effort and time for firing, and reduces the incidence of medical accidents. The process of cutting and suturing the tissue is continuous and smooth, and the edge of the tissue after anastomosis is continuously smooth. The advantages are obvious. This is the future development trend of laparoscopic stapler.

The policy continues to be positive, and the domestic stapler has entered the fast lane

At present, the concentration of the stapler industry in my country is generally low. There are more than 200 domestic related companies. The entire industry is small and scattered. Most domestic stapler companies are difficult to compete with the world's leading companies in terms of production scale, R&D capabilities and capital investment.

Especially in the field of endoscopic staplers, the first batch of domestic companies were founded in the middle of 2000. Although it has been more than 15 years since development, the current market is still dominated by import companies such as Johnson & Johnson and Medtronic.

In recent years, the state has strongly supported domestic medical devices, and policy support has become an important boost for the rapid development of stapler companies. Many government departments have issued documents requesting medical institutions to give priority to using domestic medical equipment. For example, Zhejiang Province removed dozens of medical equipment from the import list and required government procurement projects to purchase domestic products in principle. Guangdong Province reduced the list of imported medical equipment from 132 to 46, emphasizing priority purchase of domestic equipment.

In the centralized procurement of consumables, domestic production is also the preferred choice. On May 27th, the Hengyang Municipal Medical Insurance Bureau's "On the centralized procurement of consumables (drugs) related to the treatment of end-stage renal disease" pointed out that among the agreed purchases, domestically-produced products accounted for more than 90%, and imported products were selected. Accounted for less than 10% of the share.

Domestic manufacturers work together to accelerate the pace of breakthrough

Under the main theme of domestic substitution, how to break through has become the biggest challenge for domestic stapler manufacturers. First, seize the core technology and establish a competitive advantage. Through continuous research and development, domestic stapler companies continue to usher in breakthroughs to make up for the domestic technological gap.

Fenghe Medical: Launched the world's first disposable all-electric laparoscopic stapler LunarTM, which has passed the US FDA and European CE certification, and currently covers 76 countries around the world. At the same time, it is the first electric stapler product in China that has passed more than 300 registered clinical trials and obtained the NMPA Class III product registration certificate;

Yisi Medical: It has the world's first 60° super-large corner, and the shape of the titanium nail is changed to an arc, which is different from the rectangular-like of the traditional Johnson & Johnson series;

Changzhou Jianruibao: A new generation of endoscopic cutting stapler and staple cartridge, using the patented technology of "non-contour staple forming", which comprehensively improves the suturing and hemostasis performance of the product.

Introcom: The world's first to launch a full range of electric smart stapler products. There are five products in the development and research of the electric stapler series, and two products have obtained the three-category registration certificate to realize the overall platform-based electric solution. In the electric stapler market, it forms a tripartite position with Johnson & Johnson and Medtronic.

Wilkadi: The first domestically approved electric endoscopic stapler, and the third after Johnson & Johnson and Medtronic. At present, it has received a notice from the U.S. Food and Drug Administration (FDA) and has officially obtained the U.S. market access permit.

Secondly, domestic enterprises are also actively expanding overseas markets, looking for new profit growth points. It is understood that in 2019, my country's stapler equipment was exported to 106 countries and regions, with a total export value of about 72.29 million US dollars. The top three export markets are Brazil, the United Kingdom, and Italy. The top three export domestic companies are Pelt, Tianchen Medical and Rich.

With the support of policies and the improvement of technology, domestic stapler companies are completing their status conversion from follower to challenger. In the future stapler field, several domestic leading companies will inevitably be born. Which companies will eventually stand out? We will wait and see.